Teva Pharmaceutical Industries Limited (TEVJF)

Market Cap	20.82B
Revenue (ttm)	16.62B
Net Income (ttm)	-1.29B
Shares Out	n/a
EPS (ttm)	-1.14
PE Ratio	n/a
Forward PE	7.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	701
Average Volume	512
Open	19.31
Previous Close	n/a
Day's Range	19.31 - 19.31
52-Week Range	13.73 - 22.91
Beta	0.63
RSI	57.04
Earnings Date	May 7, 2025

About TEVJF

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: OTCMKTS
• Ticker Symbol: TEVJF

Financial Performance

In 2024, TEVJF's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.